SLC12A3 and Gitelman syndrome: Pathologically, the loss-of-function mutations N59I, R83W, I360T, C421Y, G463R, G731R, L859P, and R861C of NCC were identified in the patients of Gitelman Syndrome, whereas overactivation of NCC was shown to lead to hypertensive PHAII [209,210].